Raymond Woo Sells 11,112 Shares of CeriBell (NASDAQ:CBLL) Stock

CeriBell, Inc. (NASDAQ:CBLL) CTO Raymond Woo sold 11,112 shares of the business’s stock in a transaction on Friday, January 2nd. The shares were sold at an average price of $21.18, for a total transaction of $235,352.16. Following the sale, the chief technology officer owned 167,317 shares of the company’s stock, valued at $3,543,774.06. This trade represents a 6.23% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link.

Raymond Woo also recently made the following trade(s):

• On Monday, December 1st, Raymond Woo sold 11,112 shares of CeriBell stock. The shares were sold at an average price of $12.28, for a total transaction of $136,455.36.
• On Tuesday, November 11th, Raymond Woo sold 11,112 shares of CeriBell stock. The shares were sold at an average price of $12.28, for a total transaction of $136,455.36.

CeriBell Stock Up 4.4%

Shares of NASDAQ:CBLL traded up $0.92 during midday trading on Tuesday, hitting $21.73. 308,750 shares of the company’s stock were exchanged, compared to its average volume of 515,383. The company has a debt-to-equity ratio of 0.12, a current ratio of 12.65 and a quick ratio of 12.25. CeriBell, Inc. has a 12 month low of $10.01 and a 12 month high of $26.04. The company has a market cap of $806.18 million, a PE ratio of -14.39 and a beta of 1.02. The stock has a 50 day moving average price of $17.15 and a 200-day moving average price of $14.94.

CeriBell (NASDAQ:CBLL) last released its quarterly earnings results on Tuesday, November 4th. The company reported ($0.37) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.43) by $0.06. The business had revenue of $22.59 million during the quarter, compared to the consensus estimate of $21.78 million. CeriBell had a negative return on equity of 29.63% and a negative net margin of 63.35%. On average, sell-side analysts anticipate that CeriBell, Inc. will post -2.46 EPS for the current fiscal year.

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Cowen restated a “buy” rating on shares of CeriBell in a research note on Tuesday, December 9th. Weiss Ratings reiterated a “sell (e+)” rating on shares of CeriBell in a report on Wednesday, October 8th. Canaccord Genuity Group boosted their price target on shares of CeriBell from $29.00 to $30.00 and gave the stock a “buy” rating in a report on Wednesday, December 17th. Raymond James Financial started coverage on shares of CeriBell in a research note on Tuesday, October 21st. They issued a “strong-buy” rating and a $19.00 price objective for the company. Finally, JPMorgan Chase & Co. cut their target price on CeriBell from $21.00 to $17.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. One equities research analyst has rated the stock with a Strong Buy rating, six have issued a Buy rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average target price of $24.67.

Institutional Trading of CeriBell

Large investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC lifted its stake in CeriBell by 55.4% in the second quarter. Geode Capital Management LLC now owns 447,936 shares of the company’s stock valued at $8,391,000 after purchasing an additional 159,698 shares during the last quarter. Squarepoint Ops LLC bought a new stake in shares of CeriBell in the second quarter valued at $1,054,000. Police & Firemen s Retirement System of New Jersey lifted its position in shares of CeriBell by 161.0% during the 2nd quarter. Police & Firemen s Retirement System of New Jersey now owns 5,677 shares of the company’s stock valued at $106,000 after buying an additional 3,502 shares during the last quarter. F m Investments LLC bought a new position in shares of CeriBell during the 2nd quarter worth $381,000. Finally, TimesSquare Capital Management LLC raised its stake in CeriBell by 48.5% in the 2nd quarter. TimesSquare Capital Management LLC now owns 796,945 shares of the company’s stock valued at $14,927,000 after acquiring an additional 260,116 shares during the period.

CeriBell Company Profile

CeriBell Corp (NASDAQ: CBLL) is a healthcare technology company specializing in the design, manufacture and sale of automated newborn hearing screening devices. The company offers a suite of medical diagnostic tools based on otoacoustic emissions (OAE) and auditory brainstem response (ABR) technologies, enabling early detection of auditory impairments in infants. CeriBell’s solutions are used in hospitals, birthing centers and audiology clinics to support universal newborn hearing screening programs aimed at improving language development outcomes through prompt intervention.

The company’s product portfolio includes handheld and desktop screening units, proprietary software for data management, and accessories designed to streamline testing workflows.